Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma	Recruiting	Phase 2	2026-03-03		NCT07447570

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Second Affiliated Hospital, Zhejiang University, School of Medicine	561

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Second Affiliated Hospital Of Zhejiang University School of Medicine	Hangzhou	China	12

Clinical trials